Bulletin
Investor Alert

Todos Medical Ltd.

OTC: TOMDF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Aug 12, 2022, 3:59 p.m.

/zigman2/quotes/209363638/composite

$

0.03

Change

-0.0003 -0.94%

Volume

Volume 16.74m

Quotes are delayed by 20 min

/zigman2/quotes/209363638/composite

Previous close

$ 0.03

$ 0.03

Change

-0.0003 -0.94%

Day low

Day high

$0.03

$0.03

Open

52 week low

52 week high

$0.01

$0.64

Open

Company Description

Todos Medical Ltd. is an in vitro diagnostics company. It is focused on the development of novel blood tests for the early detection of cancer and Alzheimer's disease, and the distribution of comprehensive solutions for COVID-19 screening. It is also involved in the activities of breast cancer test,...

Todos Medical Ltd. is an in vitro diagnostics company. It is focused on the development of novel blood tests for the early detection of cancer and Alzheimer's disease, and the distribution of comprehensive solutions for COVID-19 screening. It is also involved in the activities of breast cancer test, such as TM-B1 and TM-B2. The company was founded by Rami Zigdon and Udi Zelig on April 22, 2010 and is headquartered in Tel Aviv, Israel.

Valuation

Price to Sales Ratio

3.25

Enterprise Value to EBITDA

-8.16

Enterprise Value to Sales

7.40

Efficiency

Total Asset Turnover

1.16

Liquidity

Current Ratio

0.53

Quick Ratio

0.35

Cash Ratio

0.02

Profitability

Gross Margin

35.60

Operating Margin

-75.93

Pretax Margin

-340.61

Net Margin

-354.16

Return on Assets

-410.09

Return on Total Capital

-232.97

Capital Structure

Total Debt to Total Assets

210.07

Officers and Executives

Name Age Officer Since Title
Dr. Herman Weiss 48 2017 Chairman
Mr. Gerald E. Commissiong 38 2020 President, Chief Executive Officer & Director
Mr. Chris Gross - 2020 Vice President-Sales Operations
Mr. Daniel Hirsch 52 - Chief Financial Officer & Director
Dr. Elise Brownell - 2020 Vice President-Research & Development

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/30/2021 Amarantus Bioscience Holdings, Inc.
CEO and Director; Director
1,051,480   Acquisition at $0.03 per share. 31,544
04/05/2021 Strategic Investment Holdings LLC
1,724,139   Disposition at $0.08 per share. 137,931
04/05/2021 Strategic Investment Holdings LLC
1,149,425   Disposition at $0.08 per share. 91,954
04/01/2021 Strategic Investment Holdings LLC
98,300   Disposition at $0.06 per share. 5,898
04/01/2021 Strategic Investment Holdings LLC
100,000   Disposition at $0.06 per share. 6,000
04/01/2021 Strategic Investment Holdings LLC
100,000   Disposition at $0.06 per share. 6,000
04/01/2021 Strategic Investment Holdings LLC
150,000   Disposition at $0.05 per share. 7,500
03/31/2021 Strategic Investment Holdings LLC
100,000   Disposition at $0.05 per share. 5,000
03/31/2021 Strategic Investment Holdings LLC
150,000   Disposition at $0.05 per share. 7,500
03/31/2021 Strategic Investment Holdings LLC
100,000   Disposition at $0.05 per share. 5,000
07/07/2020 Strategic Investment Holdings LLC
18,608,113   Acquisition at $0.08 per share. 1,488,649
04/01/2020 Strategic Investment Holdings LLC
13,008,976   Acquisition at $0.08 per share. 1,040,718
01/21/2020 Strategic Investment Holdings LLC
17,091,096   Acquisition at $0.06 per share. 1,025,465
/news/latest/company/us/tomdf

MarketWatch News on TOMDF

No News currently available for TOMDF

/news/nonmarketwatch/company/us/tomdf

Other News on TOMDF

  1. 10-K: TODOS MEDICAL LTD.

    6:19 p.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Merck's Plan B Percolates After Pfizer Announces Dominance

    4:14 a.m. Nov. 13, 2021

    - Seeking Alpha

  3. CFOs Plump Salaries, Perks to Land Elusive New Employees

    2:32 a.m. Oct. 26, 2021

    - The Wall Street Journal Interactive Edition

  4. Todos Medical re-evaluates Tollovir COVID-19 trial designs

    9:21 a.m. Oct. 4, 2021

    - Seeking Alpha

  5. 10-Q: TODOS MEDICAL LTD.

    6:01 a.m. Sept. 24, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  6. Merck Desperate To Get Back In Coronavirus Race, With A Pill

    12:18 a.m. June 26, 2021

    - Seeking Alpha

  7. Todos Medical shares rise on mid-stage COVID-19 trial launch

    10:40 a.m. April 19, 2021

    - Seeking Alpha

  8. Loading more headlines...

At a Glance

Todos Medical Ltd.

121 Derech Menachem Begin

30th Floor

Tel Aviv, TA 6701203

Phone

972 732077259

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$12.23M

Net Income

$-43.31M

Employees

23.00

/news/pressrelease/company/us/tomdf

Press Releases on TOMDF

  1. Todos Medical Reports Case Study #7 in Acute and Long COVID

    9:45 a.m. July 12, 2022

    - NewMediaWire

  2. Todos Medical Reports Case Study #7 in Acute and Long COVID

    9:40 a.m. July 12, 2022

    - GlobeNewswire

  3. Loading more headlines...
Link to MarketWatch's Slice.